MiNK Therapeutics | DEF 14A: Definitive information statements
MiNK Therapeutics | 8-K: MiNK Reports Fourth Quarter and Year-End 2023 Results
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
MiNK Therapeutics | DEF 14A: Definitive proxy statements
MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
MiNK Therapeutics | S-3: Registration statement for specified transactions by certain issuers
MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | 8-K: Current report
MiNK Therapeutics | DEF 14A: Definitive proxy statements
No Data